SCHEMBL6595023

SCHEMBL6595023

COc1ccc(C(CCN2CCCN(c3nc4ccccc4n3CCOCC(F)(F)F)CC2)CN(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TACR2 P21452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592360 0.96 TACR2 (0.39) TACR2
SCHEMBL6597771 0.95 TACR2 (0.38) TACR2
SCHEMBL6591811 0.95 HRH1 (0.38) TACR2
SCHEMBL6597593 0.94 TACR2 (0.40) TACR2
SCHEMBL6594495 0.94 TACR2 (0.37) LMNAMAPTALDH1A1TACR2
SCHEMBL6595752 0.94 TACR2 (0.39) TACR2
SCHEMBL6596138 0.94 CHRM1 (0.37)
SCHEMBL6598857 0.93 ALDH1A1 (0.45) LMNAMAPTALDH1A1
SCHEMBL6596964 0.93 TACR2 (0.39) TACR2
SCHEMBL6595046 0.93 TACR2 (0.39) TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed
US-5932571-A Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases HOECHST MARION ROUSSEL, INC. (US) 1999-08-03 US disclosed